Get started
Author

Shuichi Hiraoka

Observed name: Hiraoka, Shuichi
ORCID: 0000-0002-4151-5022
Observed ORCID: 0000-0002-4151-5022
OpenAlex ID: A5025854880
Sensory evaluation of the bitterness of asenapine using D-sorbitol pretreatment: single-blind, placebo-controlled, crossover trial
2023 · Shuhei Wada, Kunihiro Iwamoto, et al. · BMC Psychiatry · 9
PDF
Improvement in the appropriate antimicrobial usage for treating pediatric acute otitis media in Japan: A descriptive study using nation-wide electronic medical record data
2021 · Masamitsu Kono, Gen Sugita, et al. · Journal of Infection and Chemotherapy · 9
Divergence of dose–response with asenapine: a cluster analysis of randomized, double-blind, and placebo control study
2021 · Yoshiteru Takekita, Shuichi Hiraoka, et al. · CNS Spectrums · 7
Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks ( P06125 )—Secondary publication
2023 · Toshihiko Kinoshita, Yoshiteru Takekita, et al. · Neuropsychopharmacology Reports · 6
PDF
Asenapine add‐on treatment for schizophrenia adults who received antipsychotics: A 52‐week, open‐label study
2023 · Taro Kishi, Yasuhiro Iwama, et al. · Psychiatry and Clinical Neurosciences · 4
Efficacy Comparison for a Schizophrenia and a Dysuria Drug Among East Asian Populations: A Retrospective Analysis Using Multi-regional Clinical Trial Data
2021 · Kimie Sai, Eiji Nakatani, et al. · Therapeutic Innovation & Regulatory Science · 4
Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real‐world data
2023 · Yoshiteru Takekita, Shuichi Hiraoka, et al. · Neuropsychopharmacology Reports · 1
PDF
Suicide risk and antidepressant prescriptions among people with cancer: a prefecture-level ecological study
2025 · Ken Kurisu, Shuichi Hiraoka, et al. · Journal of Psychosocial Oncology Research and Practice
Predictors of continuation for asenapine from real-world data in patients with schizophrenia
2024 · Yoshiteru Takekita, Shuichi Hiraoka, et al. · Annals of General Psychiatry
Effect of single-administration of d-sorbitol pretreatment on the bitterness and continued willingness to take asenapine: a randomized, single-blind, placebo-controlled, crossover trial
2024 · Shuhei Wada, Kunihiro Iwamoto, et al. · BMC Psychiatry
PDF
Works count: 12
Citation count: 40
H-index: 4
I10-index:
Year
Topic
Type